chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Rash; lots of itching; hives; welting, in several parts of her body such as her left wrist, under her chin on her neck,underneath her arm on her right side, under her right breast, and stomach; A spontaneous report was reported by consumer, a 58-year-old female patient, who received Moderna COVID-19 Vaccine (mRNA-1273) and experienced the occurrence of rash, lots of itching/pruritus, hives/urticaria and welting in several parts of her body such as her left wrist, under her chin, on her neck, underneath her arm on her right side, under her right breast and stomach/urticaria.  The patient's medical history was not provided. Concomitant product was not provided by the reporter  On 10-Feb-2021, the patient received the first dose of mRNA-1273 (lot/batch number: 011M20A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 21-Feb-2021, the patient developed a rash and wasn't sure if it was due to a change in laundry detergent or dry skin from turning the heat on. Then she had lots of itching, rash, hives, welting, in several parts of her body such as her left wrist, under her chin, on her neck, underneath her arm on her right side, under her right breast and stomach. Treatment for the events included hydrocortisone ointment which helped.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events rash, lots of itching, hives, welting, in several parts of her body such as her left wrist, under her chin, on her neck, underneath her arm on her right side, under her right breast and stomach was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Vaccination site pain
Clinical narrative: Numbness; Tingling in leg and face; Tingling in leg and face; Extreme pain in the arm where she had vaccination; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness), the first episode of PARAESTHESIA (Tingling in leg and face), the second episode of PARAESTHESIA (Tingling in leg and face) and VACCINATION SITE PAIN (Extreme pain in the arm where she had vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness), the first episode of PARAESTHESIA (Tingling in leg and face), the second episode of PARAESTHESIA (Tingling in leg and face) and VACCINATION SITE PAIN (Extreme pain in the arm where she had vaccination). At the time of the report, HYPOAESTHESIA (Numbness) outcome was unknown and VACCINATION SITE PAIN (Extreme pain in the arm where she had vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-093549 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: AE outcome
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Injection site discolouration, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Arm sore; injection site  became red, hot and swollen; injection site  became red, hot and swollen; injection site  became red, hot and swollen; there was little bit itching on there; injection site exactly is a darker shade.; still tender; it started growing, the redness spread.; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (injection site  became red, hot and swollen), INJECTION SITE WARMTH (injection site  became red, hot and swollen), INJECTION SITE SWELLING (injection site  became red, hot and swollen), INJECTION SITE PRURITUS (there was little bit itching on there) and PAIN IN EXTREMITY (Arm sore) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced CONDITION AGGRAVATED (it started growing, the redness spread.) and INJECTION SITE PAIN (still tender). On 26-Jan-2021, the patient experienced INJECTION SITE DISCOLOURATION (injection site exactly is a darker shade.). On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (injection site  became red, hot and swollen), INJECTION SITE WARMTH (injection site  became red, hot and swollen), INJECTION SITE SWELLING (injection site  became red, hot and swollen), INJECTION SITE PRURITUS (there was little bit itching on there) and PAIN IN EXTREMITY (Arm sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE ERYTHEMA (injection site  became red, hot and swollen), INJECTION SITE WARMTH (injection site  became red, hot and swollen), INJECTION SITE SWELLING (injection site  became red, hot and swollen), INJECTION SITE PRURITUS (there was little bit itching on there), PAIN IN EXTREMITY (Arm sore), CONDITION AGGRAVATED (it started growing, the redness spread.), INJECTION SITE DISCOLOURATION (injection site exactly is a darker shade.) and INJECTION SITE PAIN (still tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-017910 (Linked Report).; Sender's Comments:  MOD-2021-017910:Same reporter/ Different patient (Daughter)
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Injection site warmth, Pain in extremity
Clinical narrative: Arm sore; injection site  became red, hot and swollen; injection site  became red, hot and swollen; injection site  became red, hot and swollen; there was little bit itching on there; injection site exactly is a darker shade.; still tender; it started growing, the redness spread.; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (injection site  became red, hot and swollen), INJECTION SITE WARMTH (injection site  became red, hot and swollen), INJECTION SITE SWELLING (injection site  became red, hot and swollen), INJECTION SITE PRURITUS (there was little bit itching on there) and PAIN IN EXTREMITY (Arm sore) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced CONDITION AGGRAVATED (it started growing, the redness spread.) and INJECTION SITE PAIN (still tender). On 26-Jan-2021, the patient experienced INJECTION SITE DISCOLOURATION (injection site exactly is a darker shade.). On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (injection site  became red, hot and swollen), INJECTION SITE WARMTH (injection site  became red, hot and swollen), INJECTION SITE SWELLING (injection site  became red, hot and swollen), INJECTION SITE PRURITUS (there was little bit itching on there) and PAIN IN EXTREMITY (Arm sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE ERYTHEMA (injection site  became red, hot and swollen), INJECTION SITE WARMTH (injection site  became red, hot and swollen), INJECTION SITE SWELLING (injection site  became red, hot and swollen), INJECTION SITE PRURITUS (there was little bit itching on there), PAIN IN EXTREMITY (Arm sore), CONDITION AGGRAVATED (it started growing, the redness spread.), INJECTION SITE DISCOLOURATION (injection site exactly is a darker shade.) and INJECTION SITE PAIN (still tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-017910 (Linked Report).; Sender's Comments:  MOD-2021-017910:Same reporter/ Different patient (Daughter)
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hypertension, Malaise, Myalgia, Nausea
Clinical narrative: feeling ill; high blood pressure; high temperature; chills; body aches; nausea; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling ill), HYPERTENSION (high blood pressure), PYREXIA (high temperature), CHILLS (chills) and MYALGIA (body aches) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included COLECALCIFEROL (VITAMIN D 3) and POTASSIUM for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced MALAISE (feeling ill), HYPERTENSION (high blood pressure), PYREXIA (high temperature), CHILLS (chills), MYALGIA (body aches) and NAUSEA (nausea). At the time of the report, MALAISE (feeling ill), HYPERTENSION (high blood pressure), PYREXIA (high temperature), CHILLS (chills), MYALGIA (body aches) and NAUSEA (nausea) outcome was unknown. Not Provided          Concomitant medications included Blood pressure medications and Cholesterol medications(names were not specified). Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.   This case was linked to MOD-2021-020516 (Patient Link).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: feeling ill; high blood pressure; high temperature; chills; body aches; nausea; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling ill), HYPERTENSION (high blood pressure), PYREXIA (high temperature), CHILLS (chills) and MYALGIA (body aches) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included COLECALCIFEROL (VITAMIN D 3) and POTASSIUM for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced MALAISE (feeling ill), HYPERTENSION (high blood pressure), PYREXIA (high temperature), CHILLS (chills), MYALGIA (body aches) and NAUSEA (nausea). At the time of the report, MALAISE (feeling ill), HYPERTENSION (high blood pressure), PYREXIA (high temperature), CHILLS (chills), MYALGIA (body aches) and NAUSEA (nausea) outcome was unknown. Not Provided          Concomitant medications included Blood pressure medications and Cholesterol medications(names were not specified). Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.   This case was linked to MOD-2021-020516 (Patient Link).
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Injection site erythema, Injection site pruritus, Injection site rash, Paraesthesia
Clinical narrative: very itchy rash on legs; burning on legs; needly sensation on legs; raised bumps at the injection site; Bull's eye rash at the injection site; painful at the injection site; itchy at the injection site; small red spot at the injection site/red at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (very itchy rash on legs), BURNING SENSATION (burning on legs), PARAESTHESIA (needly sensation on legs), VACCINATION SITE PAPULE (raised bumps at the injection site) and INJECTION SITE RASH (Bull's eye rash at the injection site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Environmental allergy. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (small red spot at the injection site/red at the injection site). On 27-Jan-2021, the patient experienced VACCINATION SITE PAPULE (raised bumps at the injection site), INJECTION SITE RASH (Bull's eye rash at the injection site), VACCINATION SITE PAIN (painful at the injection site) and INJECTION SITE PRURITUS (itchy at the injection site). On 31-Jan-2021, the patient experienced RASH PRURITIC (very itchy rash on legs), BURNING SENSATION (burning on legs) and PARAESTHESIA (needly sensation on legs). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency and TRIAMCINOLONE ACETONIDE at an unspecified dose and frequency. On 02-Feb-2021, VACCINATION SITE PAPULE (raised bumps at the injection site), INJECTION SITE RASH (Bull's eye rash at the injection site), INJECTION SITE ERYTHEMA (small red spot at the injection site/red at the injection site), VACCINATION SITE PAIN (painful at the injection site) and INJECTION SITE PRURITUS (itchy at the injection site) had resolved. At the time of the report, RASH PRURITIC (very itchy rash on legs), BURNING SENSATION (burning on legs) and PARAESTHESIA (needly sensation on legs) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic, Vaccination site pain, Vaccination site papule
Clinical narrative: very itchy rash on legs; burning on legs; needly sensation on legs; raised bumps at the injection site; Bull's eye rash at the injection site; painful at the injection site; itchy at the injection site; small red spot at the injection site/red at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (very itchy rash on legs), BURNING SENSATION (burning on legs), PARAESTHESIA (needly sensation on legs), VACCINATION SITE PAPULE (raised bumps at the injection site) and INJECTION SITE RASH (Bull's eye rash at the injection site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Environmental allergy. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (small red spot at the injection site/red at the injection site). On 27-Jan-2021, the patient experienced VACCINATION SITE PAPULE (raised bumps at the injection site), INJECTION SITE RASH (Bull's eye rash at the injection site), VACCINATION SITE PAIN (painful at the injection site) and INJECTION SITE PRURITUS (itchy at the injection site). On 31-Jan-2021, the patient experienced RASH PRURITIC (very itchy rash on legs), BURNING SENSATION (burning on legs) and PARAESTHESIA (needly sensation on legs). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency and TRIAMCINOLONE ACETONIDE at an unspecified dose and frequency. On 02-Feb-2021, VACCINATION SITE PAPULE (raised bumps at the injection site), INJECTION SITE RASH (Bull's eye rash at the injection site), INJECTION SITE ERYTHEMA (small red spot at the injection site/red at the injection site), VACCINATION SITE PAIN (painful at the injection site) and INJECTION SITE PRURITUS (itchy at the injection site) had resolved. At the time of the report, RASH PRURITIC (very itchy rash on legs), BURNING SENSATION (burning on legs) and PARAESTHESIA (needly sensation on legs) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: swelling; arm was really really hurting,red spot appeared were the shot was that was tender.; little red spot on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was really really hurting,red spot appeared were the shot was that was tender.), VACCINATION SITE ERYTHEMA (little red spot on the injection site) and VACCINATION SITE SWELLING (swelling) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Allergy. Concomitant products included FORMOTEROL FUMARATE, MOMETASONE FUROATE (DULERA) and FLUTICASONE for Asthma, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY).    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PAIN (arm was really really hurting,red spot appeared were the shot was that was tender.) and VACCINATION SITE ERYTHEMA (little red spot on the injection site). On 15-Feb-2021, the patient experienced VACCINATION SITE SWELLING (swelling). On 09-Feb-2021, VACCINATION SITE PAIN (arm was really really hurting,red spot appeared were the shot was that was tender.) had resolved. On 10-Feb-2021, VACCINATION SITE ERYTHEMA (little red spot on the injection site) had resolved. At the time of the report, VACCINATION SITE SWELLING (swelling) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Urticaria, Vaccination site pain
Clinical narrative: break out in hives all over her body; some dizziness; soreness in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (break out in hives all over her body), DIZZINESS (some dizziness) and VACCINATION SITE PAIN (soreness in the injection site) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Sulfonamide allergy (allergy to products containing sulfa).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced DIZZINESS (some dizziness) and VACCINATION SITE PAIN (soreness in the injection site). On 25-Jan-2021, the patient experienced URTICARIA (break out in hives all over her body). The patient was treated with PREDNISONE for Hives, at a dose of UNK dosage form and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, URTICARIA (break out in hives all over her body) had not resolved and DIZZINESS (some dizziness) and VACCINATION SITE PAIN (soreness in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: Hot injection site; Red injection site; Site of injection started itching; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Hot injection site), INJECTION SITE PRURITUS (Site of injection started itching) and INJECTION SITE ERYTHEMA (Red injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced INJECTION SITE PRURITUS (Site of injection started itching). On 21-Feb-2021, the patient experienced INJECTION SITE WARMTH (Hot injection site) and INJECTION SITE ERYTHEMA (Red injection site). At the time of the report, INJECTION SITE WARMTH (Hot injection site), INJECTION SITE PRURITUS (Site of injection started itching) and INJECTION SITE ERYTHEMA (Red injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Neck pain
Clinical narrative: neck pain; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck pain) and MYALGIA (muscle aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced NECK PAIN (neck pain) and MYALGIA (muscle aches). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NECK PAIN (neck pain) and MYALGIA (muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pain in extremity, Pyrexia
Clinical narrative: Low grade fever; flu like symptoms; Achy legs; This spontaneous case was reported by a health care professional and describes the occurrence of PYREXIA (Low grade fever), INFLUENZA LIKE ILLNESS (flu like symptoms) and PAIN IN EXTREMITY (Achy legs) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced PYREXIA (Low grade fever), INFLUENZA LIKE ILLNESS (flu like symptoms) and PAIN IN EXTREMITY (Achy legs). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 21-Feb-2021, PYREXIA (Low grade fever) outcome was unknown. On 22-Feb-2021, INFLUENZA LIKE ILLNESS (flu like symptoms) and PAIN IN EXTREMITY (Achy legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Mobility decreased
Clinical narrative: Really bad reactions like flu; Could not move all day; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (Really bad reactions like flu) and MOBILITY DECREASED (Could not move all day) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Really bad reactions like flu) and MOBILITY DECREASED (Could not move all day). At the time of the report, INFLUENZA LIKE ILLNESS (Really bad reactions like flu) and MOBILITY DECREASED (Could not move all day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Erythema, Flushing, Pyrexia
Clinical narrative: felt warm; shortness of breat; running fever; Dizzy; red face and flushing about 6 hours later; red face and flushing about 6 hours later; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red face and flushing about 6 hours later), FLUSHING (red face and flushing about 6 hours later), SKIN WARM (felt warm), DIZZINESS (Dizzy) and DYSPNOEA (shortness of breat) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced ERYTHEMA (red face and flushing about 6 hours later), FLUSHING (red face and flushing about 6 hours later) and DIZZINESS (Dizzy). On an unknown date, the patient experienced SKIN WARM (felt warm), DYSPNOEA (shortness of breat) and PYREXIA (running fever). At the time of the report, ERYTHEMA (red face and flushing about 6 hours later), FLUSHING (red face and flushing about 6 hours later), DIZZINESS (Dizzy), DYSPNOEA (shortness of breat) and PYREXIA (running fever) outcome was unknown and SKIN WARM (felt warm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Skin warm
Clinical narrative: felt warm; shortness of breat; running fever; Dizzy; red face and flushing about 6 hours later; red face and flushing about 6 hours later; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red face and flushing about 6 hours later), FLUSHING (red face and flushing about 6 hours later), SKIN WARM (felt warm), DIZZINESS (Dizzy) and DYSPNOEA (shortness of breat) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced ERYTHEMA (red face and flushing about 6 hours later), FLUSHING (red face and flushing about 6 hours later) and DIZZINESS (Dizzy). On an unknown date, the patient experienced SKIN WARM (felt warm), DYSPNOEA (shortness of breat) and PYREXIA (running fever). At the time of the report, ERYTHEMA (red face and flushing about 6 hours later), FLUSHING (red face and flushing about 6 hours later), DIZZINESS (Dizzy), DYSPNOEA (shortness of breat) and PYREXIA (running fever) outcome was unknown and SKIN WARM (felt warm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Dialysis.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unevaluable event; This spontaneous case was reported by a consumer and describes the occurrence of UNEVALUABLE EVENT (Unevaluable event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced UNEVALUABLE EVENT (Unevaluable event). At the time of the report, UNEVALUABLE EVENT (Unevaluable event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  the treatment information was Unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Dyspnoea, Injection site pain, Pain in extremity
Clinical narrative: Soreness in the injection side; Got pointy pain in the first two fingers of her hand; Pressure on her left side of her chest; Hurt when breath; Pain in the leg when walk and stand; Pain on the joints of her hands; Felt itching in left arm and hands; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Felt itching in left arm and hands), PAIN IN EXTREMITY (Got pointy pain in the first two fingers of her hand), CHEST DISCOMFORT (Pressure on her left side of her chest), DYSPNOEA (Hurt when breath) and PAIN IN EXTREMITY (Pain in the leg when walk and stand) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PRURITUS (Felt itching in left arm and hands). On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (Got pointy pain in the first two fingers of her hand), CHEST DISCOMFORT (Pressure on her left side of her chest), DYSPNOEA (Hurt when breath), PAIN IN EXTREMITY (Pain in the leg when walk and stand) and ARTHRALGIA (Pain on the joints of her hands). On an unknown date, the patient experienced INJECTION SITE PAIN (Soreness in the injection side). At the time of the report, PRURITUS (Felt itching in left arm and hands), PAIN IN EXTREMITY (Got pointy pain in the first two fingers of her hand), CHEST DISCOMFORT (Pressure on her left side of her chest), DYSPNOEA (Hurt when breath), PAIN IN EXTREMITY (Pain in the leg when walk and stand), ARTHRALGIA (Pain on the joints of her hands) and INJECTION SITE PAIN (Soreness in the injection side) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Soreness in the injection side; Got pointy pain in the first two fingers of her hand; Pressure on her left side of her chest; Hurt when breath; Pain in the leg when walk and stand; Pain on the joints of her hands; Felt itching in left arm and hands; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Felt itching in left arm and hands), PAIN IN EXTREMITY (Got pointy pain in the first two fingers of her hand), CHEST DISCOMFORT (Pressure on her left side of her chest), DYSPNOEA (Hurt when breath) and PAIN IN EXTREMITY (Pain in the leg when walk and stand) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PRURITUS (Felt itching in left arm and hands). On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (Got pointy pain in the first two fingers of her hand), CHEST DISCOMFORT (Pressure on her left side of her chest), DYSPNOEA (Hurt when breath), PAIN IN EXTREMITY (Pain in the leg when walk and stand) and ARTHRALGIA (Pain on the joints of her hands). On an unknown date, the patient experienced INJECTION SITE PAIN (Soreness in the injection side). At the time of the report, PRURITUS (Felt itching in left arm and hands), PAIN IN EXTREMITY (Got pointy pain in the first two fingers of her hand), CHEST DISCOMFORT (Pressure on her left side of her chest), DYSPNOEA (Hurt when breath), PAIN IN EXTREMITY (Pain in the leg when walk and stand), ARTHRALGIA (Pain on the joints of her hands) and INJECTION SITE PAIN (Soreness in the injection side) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Limb discomfort, Nausea, Vomiting
Clinical narrative: still has a very bad headache; extremely sore arm; nauseous; felt like her head split open; vomited twice (liquid brown); This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (extremely sore arm), NAUSEA (nauseous), HEADACHE (felt like her head split open), VOMITING (vomited twice (liquid brown)) and HEADACHE (still has a very bad headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023U20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced LIMB DISCOMFORT (extremely sore arm), NAUSEA (nauseous), HEADACHE (felt like her head split open) and VOMITING (vomited twice (liquid brown)). On 21-Feb-2021, the patient experienced HEADACHE (still has a very bad headache). On 21-Feb-2021, LIMB DISCOMFORT (extremely sore arm) had resolved. At the time of the report, NAUSEA (nauseous), HEADACHE (felt like her head split open), VOMITING (vomited twice (liquid brown)) and HEADACHE (still has a very bad headache) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site pruritus
Clinical narrative: Developed a hard lump in her arm; Itchiness; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE MASS (Developed a hard lump in her arm) and VACCINATION SITE PRURITUS (Itchiness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Developed a hard lump in her arm) and VACCINATION SITE PRURITUS (Itchiness). At the time of the report, VACCINATION SITE MASS (Developed a hard lump in her arm) and VACCINATION SITE PRURITUS (Itchiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow up document received on 09/Jul/2021 and contains no new information.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Nausea; Severe headache; This spontaneous case was reported by an other health care professional and describes the occurrence of NAUSEA (Nausea) and HEADACHE (Severe headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 011L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced NAUSEA (Nausea) and HEADACHE (Severe headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 21-Feb-2021, HEADACHE (Severe headache) had resolved. At the time of the report, NAUSEA (Nausea) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up information provided. Additional details regarding the event of headache, stop date and the outcome. On 21-Jul-2021: Follow up received: No new information.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: welts; itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching) and URTICARIA (welts) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PRURITUS (itching). On 23-Jan-2021, the patient experienced URTICARIA (welts). At the time of the report, PRURITUS (itching) and URTICARIA (welts) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Aphthous ulcer, Chills, Erythema, Hyperhidrosis, Injection site reaction
Clinical narrative: Sore arm, red, tiny patches at the injection site and on the opposite arm; Sore arm, red, tiny patches at the injection site and on the opposite arm; Sore arm, red, tiny patches at the injection site and on the opposite arm; Sores inside mouth, canker sores; Chills; Sweating; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm, red, tiny patches at the injection site and on the opposite arm), INJECTION SITE REACTION (Sore arm, red, tiny patches at the injection site and on the opposite arm), ERYTHEMA (Sore arm, red, tiny patches at the injection site and on the opposite arm), APHTHOUS ULCER (Sores inside mouth, canker sores) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Juvenile diabetes and Hypertension. Concomitant products included INSULIN for Type 1 diabetes mellitus.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm, red, tiny patches at the injection site and on the opposite arm), INJECTION SITE REACTION (Sore arm, red, tiny patches at the injection site and on the opposite arm), ERYTHEMA (Sore arm, red, tiny patches at the injection site and on the opposite arm), APHTHOUS ULCER (Sores inside mouth, canker sores), CHILLS (Chills) and HYPERHIDROSIS (Sweating). At the time of the report, PAIN IN EXTREMITY (Sore arm, red, tiny patches at the injection site and on the opposite arm), INJECTION SITE REACTION (Sore arm, red, tiny patches at the injection site and on the opposite arm), ERYTHEMA (Sore arm, red, tiny patches at the injection site and on the opposite arm), APHTHOUS ULCER (Sores inside mouth, canker sores), CHILLS (Chills) and HYPERHIDROSIS (Sweating) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm, red, tiny patches at the injection site and on the opposite arm; Sore arm, red, tiny patches at the injection site and on the opposite arm; Sore arm, red, tiny patches at the injection site and on the opposite arm; Sores inside mouth, canker sores; Chills; Sweating; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm, red, tiny patches at the injection site and on the opposite arm), INJECTION SITE REACTION (Sore arm, red, tiny patches at the injection site and on the opposite arm), ERYTHEMA (Sore arm, red, tiny patches at the injection site and on the opposite arm), APHTHOUS ULCER (Sores inside mouth, canker sores) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Juvenile diabetes and Hypertension. Concomitant products included INSULIN for Type 1 diabetes mellitus.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm, red, tiny patches at the injection site and on the opposite arm), INJECTION SITE REACTION (Sore arm, red, tiny patches at the injection site and on the opposite arm), ERYTHEMA (Sore arm, red, tiny patches at the injection site and on the opposite arm), APHTHOUS ULCER (Sores inside mouth, canker sores), CHILLS (Chills) and HYPERHIDROSIS (Sweating). At the time of the report, PAIN IN EXTREMITY (Sore arm, red, tiny patches at the injection site and on the opposite arm), INJECTION SITE REACTION (Sore arm, red, tiny patches at the injection site and on the opposite arm), ERYTHEMA (Sore arm, red, tiny patches at the injection site and on the opposite arm), APHTHOUS ULCER (Sores inside mouth, canker sores), CHILLS (Chills) and HYPERHIDROSIS (Sweating) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Chills, Fatigue, Pain, Pyrexia
Clinical narrative: losing smell and taste; body aches; fatigue; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (losing smell and taste), PAIN (body aches), FATIGUE (fatigue), PYREXIA (fever) and CHILLS (chills) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J202A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN (body aches), FATIGUE (fatigue), PYREXIA (fever) and CHILLS (chills). On 23-Jan-2021, the patient experienced ANOSMIA (losing smell and taste). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ANOSMIA (losing smell and taste), PAIN (body aches), FATIGUE (fatigue), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Pain at the site of injection; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the site of injection) and PAIN IN EXTREMITY (Sore arm) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at the site of injection) and PAIN IN EXTREMITY (Sore arm). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Pain at the site of injection) and PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Nausea
Clinical narrative: Nauseous; Headache; Diarrhea; Super exhausted; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), FATIGUE (Super exhausted), NAUSEA (Nauseous) and HEADACHE (Headache) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), FATIGUE (Super exhausted) and HEADACHE (Headache). On an unknown date, the patient experienced NAUSEA (Nauseous). At the time of the report, DIARRHOEA (Diarrhea), FATIGUE (Super exhausted), NAUSEA (Nauseous) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Headache, Heart rate increased
Clinical narrative: Felt off; heart was beating faster; sore arm; Fatigue; chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt off), HEART RATE INCREASED (heart was beating faster), PAIN IN EXTREMITY (sore arm), FATIGUE (Fatigue) and CHILLS (chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced FEELING ABNORMAL (Felt off), HEART RATE INCREASED (heart was beating faster), PAIN IN EXTREMITY (sore arm), FATIGUE (Fatigue), CHILLS (chills) and HEADACHE (Headache). At the time of the report, FEELING ABNORMAL (Felt off), HEART RATE INCREASED (heart was beating faster), PAIN IN EXTREMITY (sore arm), FATIGUE (Fatigue), CHILLS (chills) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.